Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome
Eur J Neurol
.
2020 Nov;27(11):2375-2377.
doi: 10.1111/ene.14435.
Authors
Y Goereci
1
,
F Schweitzer
1
,
A Wellstein
2
,
S Silling
3
,
S Borchmann
4
,
B von Tresckow
5
,
O Adams
6
,
R Martin
7
,
M Schlamann
8
,
M Schroeter
1
,
G R Fink
1
9
,
M P Wattjes
10
,
C Warnke
1
Affiliations
1
Department of Neurology, Medical Faculty, University Hospital of Köln, Köln, Germany.
2
Georgetown University Medical School, Washington, DC, USA.
3
Institute for Virology, Medical Faculty, University Hospital of Köln, Köln, Germany.
4
Department of Haematology, Medical Faculty, University Hospital of Köln, Köln, Germany.
5
Department of Haematology, University Hospital Essen, Essen, Germany.
6
Institute for Virology, Medical Faculty, University Hospital of Düsseldorf, Düsseldorf, Germany.
7
Department of Neurology, University Medical Center Zürich, Zürich, Switzerland.
8
Department of Radiology, Medical Faculty, University Hospital of Köln, Köln, Germany.
9
Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Centre Jülich, Jülich, Germany.
10
Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.
PMID:
32644211
DOI:
10.1111/ene.14435
No abstract available
Publication types
Case Reports
Research Support, Non-U.S. Gov't
Grants and funding
Open access funding enabled and organized by Projekt DEAL